Reprogramming Tumorigenesis and the Tumor Microenvironment with Flavokawains
Nath Pampita1, Babu Santha Aswani1, Bandari BharathwajChetty1
1Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati (IITG), Guwahati 781039, Assam, India.
Cancers
|July 28, 2026
Summary
Flavokawains, natural compounds from plants, show significant anticancer potential by inhibiting cancer cell growth and survival. These phytochemicals offer a promising, safer alternative or addition to traditional cancer treatments.
Area of Science:
- Phytochemistry
- Pharmacology
- Oncology
Background:
- Cancer poses a significant global health burden.
- Naturally derived compounds are explored for therapeutic potential with fewer side effects.
- Flavokawains, a subclass of chalcones, exhibit promising anticancer activities.
Purpose of the Study:
- To review and evaluate preclinical evidence on the anticancer mechanisms of flavokawains.
- To explore flavokawains' effects on cancer cells and the tumor microenvironment.
- To assess the potential of flavokawains as anticancer agents.
Main Methods:
- Compilation and critical evaluation of existing preclinical studies.
- Analysis of flavokawains' impact on cancer cell proliferation, apoptosis, and cell-cycle progression.
- Investigation of flavokawains' modulation of key molecular pathways (e.g., PI3K/Akt/mTOR, NF-κB, MAPK) and the tumor microenvironment.
Main Results:
- Flavokawains inhibit cancer cell proliferation and induce apoptosis.
- These compounds modulate critical tumorigenesis pathways like PI3K/Akt/mTOR, NF-κB, and MAPK.
- Flavokawains suppress angiogenesis, epithelial-mesenchymal transition, and cancer stem cell niches.
Conclusions:
- Flavokawains demonstrate multifaceted anticancer mechanisms and selective cytotoxicity.
- They show potential in modulating the tumor microenvironment, including angiogenesis and EMT.
- Flavokawains are promising preclinical candidates as adjuncts or alternatives to conventional chemotherapy.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...